Johnson Midwest Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
EP
Johnson Midwest Financial's ARKG Position: Q4 2021 in Review
Johnson Midwest Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 14 shares — an estimated $1K sold.
Johnson Midwest Financial first reported a position in ARKG in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.
- Johnson Midwest Financial reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
- Johnson Midwest Financial sold 14 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $1K.
- Johnson Midwest Financial first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 1 quarter.
- Johnson Midwest Financial's ARK Genomic Revolution ETF position peaked at $1K in Q3 2021.
- 460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.
Based on Johnson Midwest Financial's 13F filing for Q4 2021, filed 26 Jan 2022.